The off-label use of ketamine for treatment-resistant depression and other mental disorders has expanded rapidly in the past five years, offering many patients hope. However, recently published data suggest that a lack of safeguards ensuring safe ketamine therapy—coupled with meager implementation of guidelines—means pregnant women are at risk of exposing their fetuses to the potentially harmful drug.
“Risks of fetal ketamine exposure are often overlooked, indicating a need for
To read the full story, Register or Login
Register / Login
Get Creative with Cannabis: The Ultimate Guide to Painting and Pottery Workshops
Creative with Cannabis Cannabis and creativity go hand in hand—especially
